Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
- PMID: 22080947
- DOI: 10.1038/nature10599
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
Abstract
Upon the aberrant activation of oncogenes, normal cells can enter the cellular senescence program, a state of stable cell-cycle arrest, which represents an important barrier against tumour development in vivo. Senescent cells communicate with their environment by secreting various cytokines and growth factors, and it was reported that this 'secretory phenotype' can have pro- as well as anti-tumorigenic effects. Here we show that oncogene-induced senescence occurs in otherwise normal murine hepatocytes in vivo. Pre-malignant senescent hepatocytes secrete chemo- and cytokines and are subject to immune-mediated clearance (designated as 'senescence surveillance'), which depends on an intact CD4(+) T-cell-mediated adaptive immune response. Impaired immune surveillance of pre-malignant senescent hepatocytes results in the development of murine hepatocellular carcinomas (HCCs), thus showing that senescence surveillance is important for tumour suppression in vivo. In accordance with these observations, ras-specific Th1 lymphocytes could be detected in mice, in which oncogene-induced senescence had been triggered by hepatic expression of Nras(G12V). We also found that CD4(+) T cells require monocytes/macrophages to execute the clearance of senescent hepatocytes. Our study indicates that senescence surveillance represents an important extrinsic component of the senescence anti-tumour barrier, and illustrates how the cellular senescence program is involved in tumour immune surveillance by mounting specific immune responses against antigens expressed in pre-malignant senescent cells.
©2011 Macmillan Publishers Limited. All rights reserved
Comment in
-
Cancer: final act of senescence.Nature. 2011 Nov 23;479(7374):481-2. doi: 10.1038/479481a. Nature. 2011. PMID: 22113687 No abstract available.
-
Senescence: Tumorigenesis under surveillance.Nat Rev Cancer. 2011 Dec 1;12(1):6. doi: 10.1038/nrc3188. Nat Rev Cancer. 2011. PMID: 22129803 No abstract available.
-
When activated oncogene meets immunity: a fight to prevent liver tumor initiation.Hepatology. 2012 Jul;56(1):387-9. doi: 10.1002/hep.25733. Hepatology. 2012. PMID: 22876365 No abstract available.
Similar articles
-
Immune surveillance of senescent cells--biological significance in cancer- and non-cancer pathologies.Carcinogenesis. 2012 Jun;33(6):1123-6. doi: 10.1093/carcin/bgs124. Epub 2012 Apr 2. Carcinogenesis. 2012. PMID: 22470164 Review.
-
Cancer: final act of senescence.Nature. 2011 Nov 23;479(7374):481-2. doi: 10.1038/479481a. Nature. 2011. PMID: 22113687 No abstract available.
-
Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression.Cancer Cell. 2016 Oct 10;30(4):533-547. doi: 10.1016/j.ccell.2016.09.003. Cancer Cell. 2016. PMID: 27728804 Free PMC article.
-
CXCR6 Inhibits Hepatocarcinogenesis by Promoting Natural Killer T- and CD4+ T-Cell-Dependent Control of Senescence.Gastroenterology. 2019 May;156(6):1877-1889.e4. doi: 10.1053/j.gastro.2019.01.247. Epub 2019 Jan 30. Gastroenterology. 2019. PMID: 30710528
-
Establishing evidence for immune surveillance of β-cell senescence.Trends Endocrinol Metab. 2024 Jul;35(7):576-585. doi: 10.1016/j.tem.2024.01.003. Epub 2024 Feb 2. Trends Endocrinol Metab. 2024. PMID: 38307810 Review.
Cited by
-
Construction and validation of senescence risk score signature as a novel biomarker in liver hepatocellular carcinoma: a bioinformatic analysis.Transl Cancer Res. 2024 Sep 30;13(9):4786-4799. doi: 10.21037/tcr-23-2373. Epub 2024 Sep 12. Transl Cancer Res. 2024. PMID: 39430830 Free PMC article.
-
Alerting the immune system to DNA damage: micronuclei as mediators.Essays Biochem. 2020 Oct 26;64(5):753-764. doi: 10.1042/EBC20200016. Essays Biochem. 2020. PMID: 32844183 Free PMC article. Review.
-
Tumor cell secretion of soluble factor(s) for specific immunosuppression.Sci Rep. 2015 Mar 9;5:8913. doi: 10.1038/srep08913. Sci Rep. 2015. PMID: 25746680 Free PMC article.
-
Combinatorial approach to cancer immunotherapy: strength in numbers.J Leukoc Biol. 2016 Aug;100(2):275-90. doi: 10.1189/jlb.5RI0116-013RR. Epub 2016 Jun 2. J Leukoc Biol. 2016. PMID: 27256570 Free PMC article. Review.
-
C/EBPγ suppresses senescence and inflammatory gene expression by heterodimerizing with C/EBPβ.Mol Cell Biol. 2013 Aug;33(16):3242-58. doi: 10.1128/MCB.01674-12. Epub 2013 Jun 17. Mol Cell Biol. 2013. PMID: 23775115 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous